NYSEArca - Nasdaq Real Time Price USD

ProShares Nanotechnology ETF (TINY)

45.97 +0.07 (+0.16%)
As of April 25 at 3:21 PM EDT. Market Open.
Loading Chart for TINY
DELL
  • Previous Close 45.90
  • Open 46.08
  • Bid 46.33 x 900
  • Ask 46.79 x 1200
  • Day's Range 45.97 - 46.08
  • 52 Week Range 32.15 - 51.89
  • Volume 18
  • Avg. Volume 2,295
  • Net Assets 4.97M
  • NAV 45.90
  • PE Ratio (TTM) --
  • Yield 0.26%
  • YTD Daily Total Return 10.15%
  • Beta (5Y Monthly) 0.00
  • Expense Ratio (net) 0.58%

The index consists of companies focused on making or applying nanotechnology innovations that allow for improved products, processes, or techniques through control or measurement of material at nanoscale. The adviser seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction. The fund is non-diversified.

ProShares

Fund Family

Technology

Fund Category

4.97M

Net Assets

2021-10-26

Inception Date

Performance Overview: TINY

Trailing returns as of 4/25/2024. Category is Technology.

YTD Return

TINY
10.15%
Category
8.66%
 

1-Year Return

TINY
45.90%
Category
31.83%
 

3-Year Return

TINY
0.00%
Category
3.17%
 

People Also Watch

Holdings: TINY

Top 10 Holdings (52.24% of Total Assets)

SymbolCompany% Assets
7735.T
SCREEN Holdings Co., Ltd. 7.90%
NVDA
NVIDIA Corporation 6.57%
LRCX
Lam Research Corporation 4.90%
ASML.AS
ASML Holding N.V. 4.81%
BRKR
Bruker Corporation 4.81%
6728.T
ULVAC, Inc. 4.76%
ENTG
Entegris, Inc. 4.72%
ONTO
Onto Innovation Inc. 4.66%
AMAT
Applied Materials, Inc. 4.61%
KLAC
KLA Corporation 4.49%

Sector Weightings

SectorTINY
Technology   78.97%
Healthcare   9.67%
Industrials   4.78%
Real Estate   0.00%
Utilities   0.00%
Energy   0.00%

Related ETF News

Research Reports: TINY

  • VECO: Lowering target price to $35.00

    VEECO INSTRUMENTS INC has an Investment Rating of HOLD; a target price of $35.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • ARWR: What does Argus have to say about ARWR?

    ARROWHEAD PHARMACEUTICALS IN has an Investment Rating of HOLD; a target price of $25.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
     
  • ARWR: What does Argus have to say about ARWR?

    ARROWHEAD PHARMACEUTICALS IN has an Investment Rating of HOLD; a target price of $31.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
     
  • ARWR: Raising target price to $31.00

    ARROWHEAD PHARMACEUTICALS IN has an Investment Rating of HOLD; a target price of $31.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
     

Related Tickers